MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes

MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials

(2013) Maria Pia Sormani et al.   LANCET NEUROLOGY

Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials

(2013) L. H. Verhey et al.   NEUROLOGY

Association between pathological and MRI findings in multiple sclerosis

(2012) Massimo Filippi et al.   LANCET NEUROLOGY

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

(2010) Maria Pia Sormani et al.   Multiple Sclerosis Journal

Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach

(2010) M. P. Sormani et al.   NEUROLOGY

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach

(2009) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses

(2008) J Petkau et al.   Multiple Sclerosis Journal